"Highly different risk estimates for atypical femoral fracture with use of bisphosphonates – debate must be allowed!." Acta Orthopaedica, 83(4), pp. 319–320
Disclosure
PA has shares in a company (Addbio AB) trying to commercialize bisphosphonate coatings for implants. PA also has received consulting reimbursement and grants from Eli Lilly & Co and from Amgen.